Pacira Biosciences Inc

NASDAQ:PCRX

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is PCRX's stock price target?

Price Target

29.434 USD

According to Wall Street analysts, the average 1-year price target for PCRX is 29.434 USD with a low forecast of 23.23 USD and a high forecast of 39.9 USD.

What is the Revenue forecast for Pacira Biosciences Inc?

Projected CAGR

9%

Over the last 13 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 3 years is 9%.

What is the Gross Profit forecast for Pacira Biosciences Inc?

Projected CAGR

11%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 41%. The projected CAGR for the next 3 years is 11%.

What is the Operating Income forecast for Pacira Biosciences Inc?

Projected CAGR

110%

The compound annual growth rate for Operating Income over the next 3 years is 110%.

What is the Pre-Tax Income forecast for Pacira Biosciences Inc?

Projected CAGR

163%

The compound annual growth rate for Pre-Tax Income over the next 3 years is 163%.

What is the Net Income forecast for Pacira Biosciences Inc?

Projected CAGR

224%

The compound annual growth rate for Net Income over the next 3 years is 224%.